STAAR Surgical Company (NASDAQ:STAA) saw a downside of -1.95% to close Monday at $42.21 after subtracting -$0.84 on the day. The 5-day average trading volume is 3,056,420 shares of the company’s common stock. It has gained $43.78 in the past week and touched a new high 3 times within the past 5 days. An average of 1,395,290 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 927,632.
STAA’s 1-month performance is -23.77% or -$13.16 on its low of $40.95 reached on 08/17/23. The company’s shares have touched a 52-week low of $40.95 and high of $104.22, with the stock’s rally to the 52-week high happening on 02/02/23. YTD, STAA has lost -13.04% or -$6.33 and has reached a new high 12 times. However, the current price is down -59.50% from the 52-week high price.
Insider Transactions
STAA stock investors last saw insider trading activity on Aug 07.Holliday Keith (Chief Technology Officer) most recently sold 823 shares at $61.97 per share on Mar 17. This transaction cost the insider $51,001. Sr. VP, Comm. Ops., NA, APAC, Francese James E, sold 35,425 shares at a price of $75.00 on Sep 27.
Valuation Metrics
STAA stock has a beta of 1.12. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 6.47 while the price-to-book (PB) in the most recent quarter is 5.77.
STAAR Surgical Company’s quick ratio for the period ended June 29 was 5.60, with the current ratio over the same period at 6.10. In terms of profitability, the gross margin trailing 12 months is 78.00%. The firm’s gross profit as reported stood at $223.38 million against revenue of $284.39 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -115.18% to $6.06 million, while revenue of $2.71 million was 55.28% off the previous quarter. Analysts expected STAA to announce $0.19 per share in earnings in its latest quarter, but it posted $0.4, representing a 110.50% surprise. EBITDA for the quarter stood at more than $9.21 million. STAA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 86.95 million, with total debt at $32.49 million. Shareholders hold equity totaling $48.5 million.
Let’s look briefly at STAAR Surgical Company (STAA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 21 August was 27.73% to suggest the stock is trending oversold, with historical volatility in this time period at 30.77%.
The stock’s 5-day moving average is $42.19, reflecting a -0.40% or -$0.17 change from its current price. STAA is currently trading -26.87% above its 20-day SMA, -31.67% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -18.89% and SMA200 by-42.77%.
Stochastic %K and %D was 10.41% and 6.93% and the average true range (ATR) pointed at 1.88. The RSI (14) points at 29.87%, while the 14-day stochastic is at 10.68% with the period’s ATR at 1.98. The stock’s 9-day MACD Oscillator is pointing at -0.64 and -2.55 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for STAAR Surgical Company (NASDAQ: STAA), Canaccord Genuity downgraded it to a Hold rating. They previously had a Buy rating on the stock. Analysts offering their rating for STAA stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate STAA as a “sell,”, while 6 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 6 have offered a “buy” rating.
What is STAA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $45.00 and a high of $66.00, with their median price target at $57.00. Looking at these predictions, the average price target given by analysts is for STAAR Surgical Company (STAA) stock is $56.11.
